APC

Nakamura, "APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus," Cancer Research, vol.

Genetic factors APC The Adenomatous Polyposis Coli (APC) gene, located on chromosome 5, is a tumor suppressor, which is mutated in most of sporadic cases of colon adenocarcinomas.

Identification and characterization of the familial adenomatous polyposis coli gene.

[USPRwire, Wed Sep 23 2015] GlobalData's clinical trial report, "Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015" provides an overview of Familial Adenomatous Polyposis Coli clinical trials scenario.

FAP is an autosomal dominant disorder with 100% penetrance, caused by mutations in the adenomatous polyposis coli gene located on chromosome 5q21-q22.

Familial recurrence of HB is extremely rare outside of associated adenomatous polyposis coli (APC) families, (8) and a causative relationship between HB and interstitial deletions of 5q21.3-q23.3 (the APC gene region) is well known.

To confirm effects on Wnt signaling, analysis of tumor tissues from 5% BB-fed mice revealed lower -catenin expression and glycogen synthase kinase-3 phosphorylation with greater expression of the-catenin inhibitory protein adenomatous polyposis coli compared to controls.

Paul Cairns: Hypermethylation of the MGMT gene promoter for prediction of response to temozolomide in glioma tissue, GSTP1 and APC (adenomatous polyposis coli) hypermethylation in prostate biopsy tissue for detection of cancer, methylation of vimentin in stool-based screen for colorectal cancer, and SEPT9 (septin 9) methylation in serum DNA for colorectal cancer.

That gene, adenomatous polyposis coli (APC) and its downstream signaling molecules, are mutated or deficient in 80 percent of all human colon cancers, Wu pointed out.

Using Indivumed's highly standardized biobank, the researchers found elevated levels of mutated adenomatous polyposis coli (APC) gene in the plasma of patients with advanced stage colorectal cancers.